טוען...
Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis
Axial spondyloarthritis (axSpA) describes a group of chronic inflammatory rheumatic diseases primarily involving the axial skeleton. IL-17 is involved in the pathogenesis of numerous inflammatory diseases, including inflammatory arthritis. Until a few years ago, the only biological agents licensed f...
שמור ב:
| הוצא לאור ב: | Immunotargets Ther |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8104974/ https://ncbi.nlm.nih.gov/pubmed/33977094 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/ITT.S259126 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|